Skip to Main Content

Eris Tollkuci, PharmD, BCOP

Assistant Professor

Eris Tollkuci, Assistant Professor of Pharmacy Practice, joined the department in July 2018. Dr. Tollkuci obtained her doctor of pharmacy degree from the University of Illinois at Chicago (UIC) in 2013. She started her career with a general post graduate year residency at Rush University Medical Center (RUMC) in Chicago, IL. She then early committed at RUMC to complete her Hematology/Oncology specialty residency training. After completing her residency, she spent time working in oncology specialty pharmacy as a clinical pharmacy specialist at Northwest Memorial (NM) Hospital in Chicago, IL. Along with her role as a clinical faculty at the COP, Dr. Tollkuci is a Hematology/Oncology Clinical Pharmacist at RUMC where she had previously been working since 2016. Dr. Tollkuci is involved with the Patient Outreach Committee of the Hematology/Oncology Pharmacy Association (HOPA) and she serves as a reviewer for the Journal of Oncology Pharmacy Practice (JOPP). Her areas of interest include infectious complications in stem cell transplant, leukemia and medication safety.  

Courses

Pharmacotherapy IV

Research and Publications

Schultz K, DiGrazia L, Tollkuci E, Seddon A, Nathan S. Aprepitant versus olanzapine for prevention of acute and delayed nausea and vomiting associated with high dose melphalan and BEAM in autologous stem cell transplant patients. 2018. [in progress]

  • https://clinicaltrials.gov/ct2/show/NCT02939287

Tollkuci E, Seddon A. Influence of obesity on acute myeloid leukemia induction efficacy. 2018. [in progress]

Fisher J, Tollkuci E, Geswein L, Schultz K. Evaluation of the incidence of cytomegalovirus with various graft-versus-host-disease prophylactic regimens. 2018. [in progress]

Tollkuci E, Chalmers A, Schultz K, Dewdney S, Basu S, Usha L. Evaluation of carboplatin desensitization efficacy in ovarian cancer patients. 2018. [in progress]

Tollkuci, E. Isavuconazole therapy in a FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report. J Oncol Pharm Pract. Jan 2018.

Baptista J, Tollkuci E, Nathan S, Maciejewski JJ, Larson M, Akpek G. Bridging to second allogeneic peripheral blood stem cell transplantation with nelarabine in a patient with relapsed/refractory T-Cell ALL. Blood. Dec 2016, 128 (22) 5200.